Gulseren, Yasemin DeryaKilic, FatmaTasbent, Fatma Esenkaya2024-02-232024-02-2320221307-94412147-2939https://doi.org/10.4274/vhd.galenos.2021.2020-12-9https://hdl.handle.net/20.500.12452/16502Objectives: Hepatitis B virus (HBV) is a major global public health problem. Maternal-fetal transmission of viral hepatitis may contribute to pregnancy-related complications. This study aimed to evaluate the frequency of HBV and its possible adverse pregnancy outcomes. Materials and Methods: The study group consisted of patients followed up in the obstetrics service. Pregnancy-related discharge codes were queried approximately 2017-2019. Hepatitis B surface antigen (HBsAg) levels in serum samples were studied by chemiluminescence enzyme immunoassay method (Architect, Abbott Laboratories, USA). The HBsAg-positive group and HBsAg-negative group data were analyzed using SPSS version 22 (SPSS Inc.; Chicago, IL, USA). Results: HBsAg was positive in 255 (2.1 %) patients. Two groups compared in terms of age and there was no significant difference (p=0.45). Two groups compared in terms of pregnancy outcomes and there was no significant difference (p=0.1). Conclusion: The study group consisted of patients with pregnancy complications and HBsAg positivity was found to be 2.1%. A lower rate was found compared to other regions. Studies to be conducted in different endemic regions of Hepatitis B in our country will illuminate the effect of hepatitis B on pregnancy better.eninfo:eu-repo/semantics/openAccessHepatitis BPregnancy ComplicationsHbsag SeropositivityArticle2811417WOS:00079103650000310.4274/vhd.galenos.2021.2020-12-9